Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,152	3,739	2,047	1,254	1,132	2,590
Market Cap Growth	99.37%	82.62%	63.27%	10.73%	-56.28%	61.95%
Enterprise Value	3,808	3,456	1,797	1,089	930.79	2,572
Last Close Price	208.21	189.07	107.15	71.42	66.80	154.46
PE Ratio	33.78	30.84	-487.05	24.29	-215.48	46.66
Forward PE	32.99	35.20	53.58	35.07	-	-
PEG Ratio	2.19	2.42	3.57	2.34	-	-
PS Ratio	15.26	13.95	12.25	9.55	5.77	10.72
PB Ratio	3.99	3.68	2.47	1.79	1.90	3.15
P/TBV Ratio	4.14	3.77	2.36	1.81	1.89	3.24
P/FCF Ratio	83.63	76.44	21.50	27.22	9.44	36.98
P/OCF Ratio	82.86	75.74	21.10	25.29	8.21	32.87
EV/Sales Ratio	14.20	12.89	10.75	8.30	4.74	10.65
EV/EBITDA Ratio	47.03	46.21	142.24	23.51	17.06	16.60
EV/EBIT Ratio	80.68	84.28	-79.49	110.91	306.48	24.76
EV/FCF Ratio	77.86	70.66	18.87	23.65	7.76	36.72
Debt / Equity Ratio	0.44	0.44	0.01	0.01	0.02	0.39
Debt / EBITDA Ratio	6.04	6.04	0.56	0.13	1.61	2.09
Debt / FCF Ratio	9.23	9.23	0.07	0.13	0.73	4.63
Net Debt / Equity Ratio	-0.28	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-3.77	-3.77	-19.72	-3.54	-2.27	-0.11
Net Debt / FCF Ratio	-5.77	-5.77	-2.62	-3.56	-1.03	-0.24
Asset Turnover	0.21	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	1.25	1.25	0.58	0.56	2.60	2.31
Quick Ratio	21.18	21.18	7.94	12.11	2.45	10.24
Current Ratio	22.23	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	22.41%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	3.93%	3.95%	-4.89%	1.45%	0.63%	7.20%
Return on Invested Capital (ROIC)	6.81%	6.84%	-6.74%	1.98%	0.89%	10.30%
Return on Capital Employed (ROCE)	3.38%	3.38%	-2.70%	1.37%	0.32%	8.25%
Earnings Yield	3.04%	3.24%	-0.21%	4.12%	-0.46%	2.14%
FCF Yield	1.20%	1.31%	4.65%	3.67%	10.59%	2.70%
Buyback Yield / Dilution	-10.96%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%
Total Shareholder Return	-10.96%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q